Trumount Cosmoceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-12-2024
- Paid Up Capital ₹ 0.10 M
as on 27-12-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -24.61%
(FY 2021)
- Profit 1643.65%
(FY 2021)
- Ebitda 116.19%
(FY 2021)
- Net Worth 10.42%
(FY 2021)
- Total Assets -43.19%
(FY 2021)
About Trumount Cosmoceuticals
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jaideep Khurana and Amrutaa Khurana serve as directors at the Company.
- CIN/LLPIN
U74900PN2013PTC149444
- Company No.
149444
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 2013
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Trumount Cosmoceuticals Private Limited offer?
Trumount Cosmoceuticals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Beauty Cosmetics, Face Pack, Body Cream, Massage Creams, Body Care Products, Body Oil, Facial Kit.
Who are the key members and board of directors at Trumount Cosmoceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaideep Khurana  | Director | 14-Nov-2013 | Current |
| Amrutaa Khurana | Director | 14-Nov-2013 | Current |
Financial Performance of Trumount Cosmoceuticals.
Trumount Cosmoceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 24.61% decrease. The company also saw a substantial improvement in profitability, with a 1643.65% increase in profit. The company's net worth Soared by an impressive increase of 10.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trumount Cosmoceuticals?
In 2021, Trumount Cosmoceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trumount Cosmoceuticals?
Unlock and access historical data on people associated with Trumount Cosmoceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trumount Cosmoceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trumount Cosmoceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
